Grifols SA (GRFS)
6.84
+0.04
(+0.59%)
USD |
NASDAQ |
May 08, 16:00
6.84
0.00 (0.00%)
Pre-Market: 09:08
Grifols Market Cap: 4.645B for May 8, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| May 08, 2024 | 4.645B |
| May 07, 2024 | 4.618B |
| May 06, 2024 | 4.767B |
| May 03, 2024 | 4.462B |
| May 02, 2024 | 4.339B |
| May 01, 2024 | 4.611B |
| April 30, 2024 | 4.367B |
| April 29, 2024 | 4.401B |
| April 26, 2024 | 4.333B |
| April 25, 2024 | 4.258B |
| April 24, 2024 | 4.339B |
| April 23, 2024 | 4.401B |
| April 22, 2024 | 4.278B |
| April 19, 2024 | 4.265B |
| April 18, 2024 | 4.441B |
| April 17, 2024 | 4.468B |
| April 16, 2024 | 4.604B |
| April 15, 2024 | 4.441B |
| April 12, 2024 | 4.455B |
| April 11, 2024 | 4.516B |
| April 10, 2024 | 4.733B |
| April 09, 2024 | 4.876B |
| April 08, 2024 | 4.951B |
| April 05, 2024 | 4.815B |
| April 04, 2024 | 4.659B |
| Date | Value |
|---|---|
| April 03, 2024 | 4.679B |
| April 02, 2024 | 4.604B |
| April 01, 2024 | 4.536B |
| March 28, 2024 | 4.536B |
| March 27, 2024 | 4.516B |
| March 26, 2024 | 4.401B |
| March 25, 2024 | 4.319B |
| March 22, 2024 | 4.224B |
| March 21, 2024 | 4.604B |
| March 20, 2024 | 4.271B |
| March 19, 2024 | 4.115B |
| March 18, 2024 | 4.109B |
| March 15, 2024 | 4.163B |
| March 14, 2024 | 3.912B |
| March 13, 2024 | 4.305B |
| March 12, 2024 | 4.271B |
| March 11, 2024 | 4.597B |
| March 08, 2024 | 4.754B |
| March 07, 2024 | 3.810B |
| March 06, 2024 | 3.715B |
| March 05, 2024 | 4.190B |
| March 04, 2024 | 4.502B |
| March 01, 2024 | 4.794B |
| February 29, 2024 | 5.100B |
| February 28, 2024 | 6.343B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
3.715B
Minimum
Mar 06 2024
17.53B
Maximum
Feb 21 2020
9.603B
Average
8.909B
Median
May 23 2022
Market Cap Benchmarks
| DBV Technologies SA | 133.81M |
| Adaptimmune Therapeutics PLC | 281.38M |
| Akari Therapeutics PLC | 11.49M |
| Biodexa Pharmaceuticals Plc | 4.385M |
| NuCana PLC | 7.760M |
Market Cap Related Metrics
| PE Ratio | 21.99 |
| PS Ratio | 0.644 |
| Price to Book Value | 0.7211 |
| Price | 6.84 |
| Earnings Yield | 4.55% |
| Operating PE Ratio | 5.778 |
| Normalized PE Ratio | 32.09 |